Examination of a large scale, integrated cancer genomic dataset of the MSKCC Prostate Oncogenome Project [28] indicated that GATA2 gene expression was significantly elevated in metastatic prostate cancer samples (Fig. 2A). The gene discussed is GATA2; the disease is metastatic prostate carcinoma.